Skip to content
Recall Observatory FDA recall evidence

Drug product

XZEN PLATINUM, 750 mg, Distributed by: XZEN, Los Angeles, CA.

D-1340-2014

January 09, 2014

Class I

Product summary

Firm
Schindele Enterprises dba Midwest Wholesale
Event
Event 67228
Status
Terminated
Classification
Class I
Quantity
89 blister packs
Official record key
drug-enforcement:D-1340-2014

Official wording

Reason: Marketed Without an Approved NDA/ANDA: These dietary supplements contain undeclared sildenafil, an analogue of sildenafil, and/or tadalafil.

Code information: Lot 130520PL Exp. 05/31/2017

Distribution pattern: Distributed to PA, IL, TX, IA, GA, CT, FL, CA, LA, NY, MD, NV, and WI

Derived failure modes

  • Unknown

    reason.no_named_rule · v1.0.0

    Marketed Without an Approved NDA/ANDA: These dietary supplements contain undeclared sildenafil, an analogue of sildenafil, and/or tadalafil.